跳至主要内容
临床试验/CTRI/2024/08/071920
CTRI/2024/08/071920尚未招募3 期

Extended field versus pelvic only Intensity modulated radiotherapy with concurrent chemoradiotherapy in stage III cervical cancer patients- a prospective randomized phase III study - nil

SAIMS Indore0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Biopsy proven Carcinoma cervix (squamous, adeno or adeno-squamous) stage III (IIIA, IIIB, IIIc1)
  • Karnoffsky performance status more than 70.Normal Hemogram-Hemoglobinmore than8 g/dl, Total Leukocyte count more than 4,000 cells/mm3, Absolute neutrophil count more than 1500 cells/mm3, Platelet count more than 100000 cells/mm3.Normal liver and kidney function tests (urea less than 40, Creatinine less than 1.2 mg/dl).Negative pregnancy test for women of child bearing potential.Willing to sign the written informed consent prior to study.No other synchronous malignancy

排除标准

  • 1. Positive para-aortic LN’s on imaging (i.e. stage IIIC2)
  • 2. Uncontrolled diabetes or hypertension
  • 3. Previous history of receiving radiotherapy
  • 4. Underwent surgical management for carcinoma cervix

研究者

发起方
SAIMS Indore

相似试验